rnationally. We are on track to launch in Thailand, Belgium, and France, are in a great position to expand into additional markets, and have been taking advantage of new opportunities that continue to present themselves to our BabyCare subsidiary in China."
Braun, who starts his new position at USANA's corporate office effective immediately, will fill Macuga's previous position.
Prior to his new role as Chief Communications Officer, Macuga spent 15 successful years with the Chrysler Corporation before coming to USANA in 2007. Since then, he has built an award-winning PR and social media department from the ground up, expanded USANA's global marketing reach and helped the company achieve record growth in sales.
For more information about USANA's product and company, visit www.usana.com.
About USANA: USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, energy and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, China, South Korea, Singapore, Malaysia, the Philippines, Mexico, the Netherlands and the United Kingdom. Learn more at our website (www.USANA.com), read our blog (www.whatsupUSANA.com), like us on Facebook (www.facebook.com/usanahealthsciences), or follow us on Twitter (@usanainc)
Media Contact: Ashley Collins
Executive Director of Marketing, PR, and Social Media
USANA Health Sciences, Inc.
Page: 1 2 3 Related medicine technology :1
|SOURCE USANA Health Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management2
. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management3
. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer4
. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting5
. U.S. Preventive Medicine Acquires Specialty Disease Management6
. Cellectar Expands Clinical Management Team7
. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels8
. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo9
. Lilly Receives NCQA Design Certification for Depression Care Management Program10
. Micromet Announces Changes in Management Team11
. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain